woman accus put bleach daughter eye sitemap natur news blog 02 may 2012 00 33 bst post byami maxmen categori biolog biotechnolog industri first time today us feder drug administr fda approveda drug produc plant among cheer news scientist advoc bio pharm decad drug elelyso taliglucera alfa sooth symptom patient rare lysosom storag disordergaucherdisea caus problem rang bone infect anemia scientist isra biotechprotalix biotherapeuticsdevelop method creat enzym patient lack carrot cell patient treat result enzym taliglucera alfa clinic trial fare least well given anoth enzym replac therapi market cerezym wonder anoth option avail say rhonda buyer execut director thenat gaucher foundationin tucker georgia hope elelyso help prevent drug shortag like 2009 2011 patient reli cerezym alon peopl whose symptom control year bone issu terribl fatigu went hospit recollect manufactur two gaucher drug genzymein us andshirein ireland produc therapeut enzym within hamster cell structur elelyso resembl genzym cerezym cheaper produc high mainten anim cell cultur requir virus pathogen contamin mammalian stock dont threaten plant cell cultur decad research abl genet manipul plant produc human enzym 2006 depart agricultur approv chicken vaccin produc plant cell assuag concern plant deriv biolog human use prove much difficult therefor scientist drug manufactur develop therapeut enzym antibodi vaccin plant say elelyso approv may make regulatori process straight forward alert big pharmaceut compani investor potenti profit plant platform prior fdas announc today ritu baral research analyst base new york canaccord genuiti said drug get approv would huge proof concept entir platform although compani poi treat 000 patient baral say uncertain market us brand loyalti genzym shire howev fact elelyso cost 25 less cerezym might sway buyer sixti percent profit us sale go pharmaceut giant pfizer made deal protalix 2009 howev long isra govern approv drug profit countri go protalix israel repr relat larg slice pie askenazi jew disproport affect disea david aviez presid chief execut protalix carmiel quit optimist carrot made drug compani pipelin earlier year protalix began plan phase clinic trial protein treat anoth enzym relat disord fabri disea approv demonstr proof concept power technolog make larg number protein aviez say readi make mani 02 may 2012 03 28 bst report comment perhap escap author attent morphin digitali name two plant made time 02 may 2012 03 29 bst report comment perhap escap author attent morphin digitali name two plant made time need tolog inorregisterto comment 23 apr 2012 ivan semeniuk 03 apr 2012 natasha gilbert 25 apr 2012 daniel cressey 09 apr 2012 eric hand 04 apr 2012 erika check hayden 23 apr 2012 ivan semeniuk 04 apr 2012 erika check hayden 04 apr 2012 john whitfield 09 apr 2012 heidi ledford 27 apr 2012 helen thompson 25 apr 2012 daniel cressey 27 apr 2012 helen thompson 04 apr 2012 brendan maher 04 apr 2012 erika check hayden 07 dec 2009 geoffrey brumfiel blogrol blogrol blogrol blogrol blogrol 2012 natur publish group divi macmillan publish limit right reserv partner ofagora hinari oar inasp orcid crossref counter